VERTEX PHARMA CO LTD has a total of 20 patent applications. Its first patent ever was published in 1996. It filed its patents most often in China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ARGENTA DISCOVERY LTD, 7TM PHARMA AS and PROXIMAGEN LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 20 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Basic materials chemistry | |
#5 | Materials and metallurgy | |
#6 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Ronald Knegtel | 5 |
#2 | Janos Pitlik | 4 |
#3 | Perni Robert B | 4 |
#4 | Juan-Miguel Jimenez | 3 |
#5 | Pan Li | 3 |
#6 | Cottrell Kevin M | 3 |
#7 | David Kay | 3 |
#8 | Alistair Rutherford | 2 |
#9 | Sanjay Patel | 2 |
#10 | Guy Brenchley | 2 |
Publication | Filing date | Title |
---|---|---|
CN101360748A | Inhibitors of c-met and uses thereof | |
CN1942466A | Caspase inhibitors and uses thereof | |
CN1906208A | Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases | |
CN1761653A | Processes for the preparation of N-heteroaryl-N-aryl-amines by reacting N-aryl carbamate with halo-heteroaryl and analogous processes | |
CN1742012A | The Triazolopyridazines that can be used as kinases inhibitor | |
CN1926132A | Pyrazole compounds useful as protein kinase inhibitors |